We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$15.9B
AUM Growth
+$519M
Cap. Flow
+$52.7M
Cap. Flow %
0.33%
Top 10 Hldgs %
30.27%
Holding
3,020
New
223
Increased
1,521
Reduced
789
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 29.92%
2 Financials 11.64%
3 Healthcare 10.79%
4 Communication Services 8.92%
5 Consumer Discretionary 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLLI icon
2176
Ollie's Bargain Outlet
OLLI
$4.8B
$9.23K ﹤0.01%
94
MNTK icon
2177
Montauk Renewables
MNTK
$243M
$9.2K ﹤0.01%
1,614
+314
+24% +$1.45K
IRWD icon
2178
Ironwood Pharmaceuticals
IRWD
$669M
$9.19K ﹤0.01%
1,410
-90
-6% -$637
NVRI icon
2179
Enviri
NVRI
$615M
$9.11K ﹤0.01%
1,056
HYLN icon
2180
Hyliion Holdings
HYLN
$701M
$9.09K ﹤0.01%
5,611
+5,581
+18,603% +$8.29K
ALHC icon
2181
Alignment Healthcare
ALHC
$2.86B
$9.04K ﹤0.01%
1,156
+316
+38% +$2.06K
CSW
2182
CSW Industrials
CSW
$5.67B
$9.02K ﹤0.01%
34
+11
+48% +$2.73K
CBUS icon
2183
Cibus
CBUS
$146M
$8.87K ﹤0.01%
+900
New +$13.6K
FLGT icon
2184
Fulgent Genetics
FLGT
$524M
$8.85K ﹤0.01%
451
+266
+144% +$5.55K
III icon
2185
Information Services Group
III
$251M
$8.85K ﹤0.01%
+3,010
New +$10.1K
PLMR icon
2186
Palomar
PLMR
$3.46B
$8.85K ﹤0.01%
109
+96
+738% +$7.82K
LPRO
2187
DELISTED
Open Lending Corp
LPRO
$8.71K ﹤0.01%
1,561
+175
+13% +$1.01K
CRBU icon
2188
Caribou Biosciences
CRBU
$165M
$8.69K ﹤0.01%
5,298
+4,223
+393% +$13.5K
BALY icon
2189
Bally's
BALY
$637M
$8.65K ﹤0.01%
723
+49
+7% +$626
EDIT icon
2190
Editas Medicine
EDIT
$432M
$8.62K ﹤0.01%
1,846
+328
+22% +$1.85K
CSTL icon
2191
Castle Biosciences
CSTL
$988M
$8.51K ﹤0.01%
391
+63
+19% +$1.4K
XPOF icon
2192
Xponential Fitness
XPOF
$208M
$8.44K ﹤0.01%
541
-9
-2% -$111
SDRL icon
2193
Seadrill
SDRL
$2.92B
$8.39K ﹤0.01%
163
+84
+106% +$4.25K
ATLC icon
2194
Atlanticus Holdings
ATLC
$1.45B
$8.37K ﹤0.01%
297
+7
+2% +$187
BBBY
2195
Bed Bath & Beyond
BBBY
$423M
$8.36K ﹤0.01%
703
-241,307
-100% -$4.28M
NVST icon
2196
Envista
NVST
$4.53B
$8.31K ﹤0.01%
500
-280
-36% -$5.29K
EVRI
2197
DELISTED
Everi Holdings
EVRI
$8.31K ﹤0.01%
989
-31,568
-97% -$258K
EYE icon
2198
National Vision
EYE
$1.8B
$8.23K ﹤0.01%
629
-10
-2% -$164
SPY icon
2199
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$8.19K ﹤0.01%
15
-9,503
-100% -$4.97M
CDMO
2200
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$8.11K ﹤0.01%
1,136
+376
+49% +$2.88K

Similar funds

Nisa Investment Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Nisa Investment Advisors held 3,020 positions worth $15.9B, up 3.4% from $15.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nisa Investment Advisors's Q2 2024 filing shows 223 new, 1,521 increased, 789 reduced and 86 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 1,750,000 shares worth $74.5M. The largest sale was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $52.9M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • Nisa Investment Advisors's largest Q2 2024 buy was iShares MSCI Emerging Markets ETF: 1,750,000 shares worth $74.5M.
  • Nisa Investment Advisors added most to NVIDIA in Q2 2024, an estimated $63.9M increase.
  • Nisa Investment Advisors's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $30.6M.
  • Nisa Investment Advisors fully exited iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $52.9M.
  • Nisa Investment Advisors's ten largest holdings make up 30% of its $15.9B portfolio in Q2 2024.
  • Nisa Investment Advisors opened 223 new positions and closed 86 in Q2 2024.
  • Nisa Investment Advisors's portfolio value rose 3.4% quarter-over-quarter to $15.9B.

Based on Nisa Investment Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.